13h
A CT man allegedly used drones to smuggle drugs into a prison. And made drugs called ‘bath salts.’
In 2023, a judge had granted his request for early termination from prison, which claimed his “rehabilitation was complete,” ...
NCT’s Jeno and Jaemin’s upcoming short-form drama is gearing up for its release! On January 2, new short-form platform KITZ unveiled the first poster for “WIND UP.” “WIND UP” is a coming-of-age drama ...
TEMPE -- The Arizona State Sun Devils have faltered a bit heading into Big 12 play, losing two consecutive games ahead of the start of the league slate. The Big 12 is widely considered the best ...
The annual Oscar short lists, which whittle down 12 of the ceremony’s 24 categories ahead of nominations, usually offer some of the season’s most important tea leaves. Tuesday’s lists once again made ...
The Los Angeles Lakers’ long-shot hopes of acquiring Giannis Antetokounmpo may be improving as several teams with the strongest trade assets are now believed to be unlikely participants if the ...
The big debate in the US Treasury market over the extent of Federal Reserve interest-rate cuts ahead is about to heat up with a string of pivotal economic data releases. This week will go a long way ...
The new Path of Exile 2 league has arrived, and with it the hottest-topic class in town. The PoE 2 Druid has long been the most highly anticipated addition to the ARPG, and I can already feel my ...
Shares of the Roomba maker are up 72% in 4 days, and retail investors think it's a new short-squeeze
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Samuel O'Brient Every time Samuel publishes a story, you’ll get an alert straight to your inbox ...
President Trump wants to make cars cheaper again. His latest proposal would roll back the strict fuel economy rules introduced under the Biden administration and the sales pitch is simple. Less ...
Investor Martin Shkreli’s big biotech short position is blowing up after the stock’s monumental rally over the past week, following a major clinical catalyst. Popularly known as “Pharma bro,” Shkreli ...
Wall Street analysts forecast that UiPath (PATH) will report quarterly earnings of $0.14 per share in its upcoming release, pointing to a year-over-year increase of 27.3%. It is anticipated that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results